Ondřej Šorejs

Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib

Ondřej Fiala, Miloš Pešek, Jindřich Fínek et al. · Neoplasma · 2016 · 61 citations · Full text

Medicine, Oncology, Pharmacology +14

Incidental Use of Beta-Blockers Is Associated with Outcome of Metastatic Colorectal Cancer Patients Treated with Bevacizumab-Based Therapy: A Single-Institution Retrospective Analysis of 514 Patients

Ondřej Fiala, Pavel Ostašov, Ondřej Šorejs et al. · Cancers · 2019 · 38 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

The association of miR-126-3p, miR-126-5p and miR-664-3p expression profiles with outcomes of patients with metastatic colorectal cancer treated with bevacizumab

Ondřej Fiala, Pavel Pitule, Petr Hošek et al. · Tumor Biology · 2017 · 32 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Impact of Concomitant Cardiovascular Medication on Survival of Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib or Pazopanib in the First Line

Ondřej Fiala, Pavel Ostašov, Aneta Rozsypalová et al. · Targeted Oncology · 2021 · 18 citations

Medicine, Oncology, Pharmacology +13

Epidermal Growth Factor Receptor Gene Amplification in Patients with Advanced-stage NSCLC.

Ondřej Fiala, Miloš Pešek, Jindřich Fínek et al. · PubMed · 2016 · 16 citations

Medicine, Molecular Genetics, Oncology +17